Immunitas Therapeutics
Dr. Jiaping Gu is Vice President at Hillhouse Capital. He joined Hillhouse in 2017 and is part of its global bioventure team. Prior to that, he had various positions at multiple pharmaceutical companies and academic institutions. Dr. Gu received his Ph.D. in Neuroscience from Rutgers University and B.S. in Biology from Tsinghua University in Beijing, China.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Immunitas Therapeutics
Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single-cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering.